Nearly 40 million older American men suffer prostatic hyperplasia (BPH), a common, non-cancerous condition that can significantly affect quality of life.
BPH, also known as enlarged prostate, can block the flow of urine out of the bladder and cause bladder, urinary tract, or kidney problems. Symptoms of the condition include the urgent need to urinate, difficulty starting a urine stream, and more frequent urination at night.
“When BPH is left untreated, those with the condition may be at risk for permanent bladder damage, urinary tract infections, or other problems that develop over time,” explains CentraState urologist Troy Sukkarieh, MD.
UroLift Minimally Invasive Technology
Most men with BPH take prescription medications, which may not provide adequate relief and can cause dizziness, fatigue, and sexual dysfunction. But new technology now available at CentraState enables effective, minimally invasive treatment of the condition.
With the UroLift® 2 System, patients can get rapid, lasting relief from BPH. During the one-hour outpatient procedure, the device provides access to the obstructed urethra. Then, tiny Urolift Implants are placed to hold open the obstructed pathway that is blocking urine flow. Unlike medications, the procedure treats the blockage directly, instead of treating its symptoms. As a result, it doesn’t require ongoing medication or the removal of prostate tissue.
“This technology allows us to perform the procedure in just a few minutes, so the total time spent at the hospital is only two to four hours rather than days,” says Dr. Sukkarieh. “There is very little recovery time because most men don’t need a catheter, and patients have been very pleased with the results and lack of side effects.”
To find a urologist at CentraState, visit centrastate.com/find-a-physician or call 866-CENTRA7 (866-236-8727).
